Janina Buck

Friedrich-Alexander-Universität Erlangen-Nürnberg — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index5.3kcitations39works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA and protein synthesis mechanisms(27), RNA modifications and cancer(15), DNA and Nucleic Acid Chemistry(10), RNA Research and Splicing(9), RNA Interference and Gene Delivery(9)

Publications39 total

Cover Feature: Triskelion‐Shaped Hexabenzocoronenes: Synthesis and Characterization of Tris‐Substituted HBC Derivatives (Chem. Eur. J. 5/2025)
Chemistry - A European Journal·2025Open Access
Triskelion‐Shaped Hexabenzocoronenes: Synthesis and Characterization of Tris‐Substituted HBC Derivatives
Chemistry - A European Journal·2024· 4 citedOpen Access
Carpet Beater Molecules: Synthesis and Characterization of Functional Hexa‐<i>peri</i>‐benzocoronene–Alkyne Coupling Products
European Journal of Organic Chemistry·2023· 3 citedOpen Access
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Nature·2017· 2.4k cited
Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy
Cancer Research·2017· 4 cited
Pausing guides RNA folding to populate transiently stable RNA structures for riboswitch-based transcription regulation
eLife·2017· 72 citedOpen Access
Author response: Pausing guides RNA folding to populate transiently stable RNA structures for riboswitch-based transcription regulation
2017· 1 citedOpen Access
Abstract A004: Systemic RNA vaccines: Connecting effective cancer immunotherapy with antiviral defense mechanisms
Cancer Immunology Research·2016
Abstract CT032: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma
Cancer Research·2016· 7 cited
Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trial
Cancer Research·2016· 5 cited
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Nature·2016· 1.7k cited
Abstract B041: A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanoma
Cancer Immunology Research·2016· 3 cited
Abstract CT201: The Mutanome Engineered RNA Immuno-Therapy (MERIT) project
Cancer Research·2015· 1 cited
Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes
Nucleic Acids Research·2014· 54 citedOpen Access
The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation
Bioorganic & Medicinal Chemistry Letters·2013· 25 cited
mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy·2012· 71 cited
Mechanisms for differentiation between cognate and near-cognate ligands by purine riboswitches
RNA Biology·2012· 11 citedOpen Access
RNA as a Drug Target
2012· 2 cited
Functional Dynamics of RNA Ribozymes Studied by NMR Spectroscopy
Methods in molecular biology·2012· 12 cited
Time-Resolved NMR-Studies of DNA I-Motif Formation Reveal Kinetic Partitioning Mechanism
Biophysical Journal·2012· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Harald Schwalbe(25), Boris Fürtig(16), Jens Wöhnert(13), Uğur Şahin(11), Andreas N. Kuhn(11), J. Noeske(10), Jan Diekmann(8), Mustafa Diken(8), Sebastian Kreiter(8), Anna Wacker(8), Heinrich Haas(7), Evelyna Derhovanessian(6), Sebastian Attig(6), Christoph Huber(6), Carmen Loquai(6), Christian Richter(6), Sandra Heesch(5), Richard Rae(5), Özlem Türeci(5), Lena M. Kranz(5)